mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.05 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |